266 related articles for article (PubMed ID: 28388719)
1. The Practical Use of AbobotulinumtoxinA in Aesthetics.
Kane MA; Monheit G
Aesthet Surg J; 2017 May; 37(suppl_1):S12-S19. PubMed ID: 28388719
[TBL] [Abstract][Full Text] [Related]
2. Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.
Nestor M; Ablon G; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S20-S31. PubMed ID: 28388717
[TBL] [Abstract][Full Text] [Related]
3. AbobotulinumtoxinA: A 25-Year History.
Monheit GD; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S4-S11. PubMed ID: 28388718
[TBL] [Abstract][Full Text] [Related]
4. New Uses of AbobotulinumtoxinA in Aesthetics.
Schlessinger J; Gilbert E; Cohen JL; Kaufman J
Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
[TBL] [Abstract][Full Text] [Related]
5. Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.
Cohen JL; Scuderi N
Aesthet Surg J; 2017 May; 37(suppl_1):S32-S44. PubMed ID: 28388721
[TBL] [Abstract][Full Text] [Related]
6. Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update.
Kaminer MS; Cox SE; Fagien S; Kaufman J; Lupo MP; Shamban A
J Drugs Dermatol; 2020 Apr; 19(4):s5-15. PubMed ID: 32243120
[TBL] [Abstract][Full Text] [Related]
7. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic indications for botulinum A toxin.
Foster JA; Wulc AE; Holck DE
Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
[TBL] [Abstract][Full Text] [Related]
9. Microbotulinum: A Quantitative Evaluation of Aesthetic Skin Improvement in 62 Patients.
Diaspro A; Calvisi L; Manzoni V; Sito G
Plast Reconstr Surg; 2020 Nov; 146(5):987-994. PubMed ID: 33136941
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A for the treatment of glabellar rhytides.
Carruthers A; Carruthers J
Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
[TBL] [Abstract][Full Text] [Related]
11. Oculoplastic experience with the cosmetic use of botulinum A exotoxin.
Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R
Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740
[TBL] [Abstract][Full Text] [Related]
12. Anatomy of the Lower Face and Botulinum Toxin Injections.
Trévidic P; Sykes J; Criollo-Lamilla G
Plast Reconstr Surg; 2015 Nov; 136(5 Suppl):84S-91S. PubMed ID: 26441118
[TBL] [Abstract][Full Text] [Related]
13. Ten Mistakes To Avoid When Injecting Botulinum Toxin.
Ruiz-Rodriguez R; Martin-Gorgojo A
Actas Dermosifiliogr; 2015; 106(6):458-64. PubMed ID: 25956528
[TBL] [Abstract][Full Text] [Related]
14. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.
de Sanctis Pecora C; Shitara D
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33670477
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
Blumenfeld AM; Silberstein SD; Dodick DW; Aurora SK; Brin MF; Binder WJ
Headache; 2017 May; 57(5):766-777. PubMed ID: 28387038
[TBL] [Abstract][Full Text] [Related]
17. Mandibular Rim Trilogy with Botulinum Toxin Injection: Reduction, Projection, and Lift.
Zhou R; Pan B; Wang C; Wang D
Facial Plast Surg; 2017 Feb; 33(1):102-108. PubMed ID: 28226378
[TBL] [Abstract][Full Text] [Related]
18. Practical aspects of cosmetic botulinum toxin.
Mannor GE
Int Ophthalmol Clin; 2005; 45(3):99-106. PubMed ID: 15970769
[No Abstract] [Full Text] [Related]
19. Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial.
Ascher B; Kestemont P; Boineau D; Bodokh I; Stein A; Heckmann M; Dendorfer M; Pavicic T; Volteau M; Tse A; Picaut P; Rzany B
Aesthet Surg J; 2018 Feb; 38(2):183-191. PubMed ID: 28200002
[TBL] [Abstract][Full Text] [Related]
20. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
Matarasso SL
Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
